0001843655-21-000001.txt : 20210203 0001843655-21-000001.hdr.sgml : 20210203 20210203162715 ACCESSION NUMBER: 0001843655-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 EFFECTIVENESS DATE: 20210203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Entheon Biomedical Corp. / Federal CENTRAL INDEX KEY: 0001843655 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388338 FILM NUMBER: 21586532 BUSINESS ADDRESS: STREET 1: 211-3030 LINCOLN AVENUE CITY: COQUITLAM STATE: A1 ZIP: V3B 6B4 BUSINESS PHONE: 604-562-3932 MAIL ADDRESS: STREET 1: 211-3030 LINCOLN AVENUE CITY: COQUITLAM STATE: A1 ZIP: V3B 6B4 D 1 primary_doc.xml X0708 D LIVE 0001843655 Entheon Biomedical Corp. / Federal 211-3030 LINCOLN AVENUE COQUITLAM A1 BRITISH COLUMBIA, CANADA V3B 6B4 604-562-3932 CANADA (FEDERAL LEVEL) M.P.V. Explorations Inc. MPV Exploration Inc. None Corporation true Timothy Ko 211-3030 Lincoln Avenue Coquitlam A1 BRITISH COLUMBIA, CANADA V3B 6B4 Executive Officer Director Brandon Schwabe 211-3030 Lincoln Avenue Coquitlam A1 BRITISH COLUMBIA, CANADA V3B 6B4 Executive Officer Christopher Gondi 211-3030 Lincoln Avenue Coquitlam A1 BRITISH COLUMBIA, CANADA V3B 6B4 Director Ruth Chun 211-3030 Lincoln Avenue Coquitlam A1 BRITISH COLUMBIA, CANADA V3B 6B4 Director Kelly Pladson 211-3030 Lincoln Avenue Coquitlam A1 BRITISH COLUMBIA, CANADA V3B 6B4 Executive Officer Andrew Hegle 211-3030 Lincoln Avenue Coquitlam A1 BRITISH COLUMBIA, CANADA V3B 6B4 Executive Officer Director Biotechnology No Revenues 06b false 2021-01-11 true true true true true Each unit is comprised of 1 common share and 1/2 of one non-transferable common share purchase warrant. Each whole warrant is exercisable for 1 common share at an exercise price of Cdn$1.00 per share for a period of 24 months, subject to acceleration. false 0 1707188 31390 1675798 The additional $1,675,798.00 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on 1/11/2021, which was Cdn$1.2788=US$1.00. false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Entheon Biomedical Corp. / Federal Kelly Pladson Kelly Pladson Corporate Secretary 2021-02-03